Opportunity Information: Apply for PAR 08 195

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIDCR Clinical Trial Planning Grant (R34)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121 Oral Diseases and Disorders Research.
  • This funding opportunity was created on Dec 5, 2008 and posted on Jul 9, 2008.
  • Applicants must submit their applications by Sep 7, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Small businesses Private institutions of higher education Public and State controlled institutions of higher education County governments Public housing authorities/Indian housing authorities State governments Others (see text field entitled Additional Information on Eligibility for clarification) Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
Apply for PAR 08 195

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIDCR Clinical Trial Planning Grant (R34) opportunity (Funding Opportunity Number PAR 08-195) is a discretionary NIH grant program run through the National Institute of Dental and Craniofacial Research (NIDCR). Its central aim is to fund the detailed planning work needed before launching an investigator-initiated interventional clinical trial in the dental, oral, and craniofacial space. Rather than paying for the full execution of a trial, this mechanism supports the upfront effort required to design the study rigorously and prepare all the core materials that would be expected in a later full-scale trial application.

This FOA is specifically focused on planning for Phase I, II, III, or IV interventional clinical trials, and it explicitly includes interventional behavioral studies (often described as Stage I through Stage IV behavioral intervention research). The intent is to help investigators move from an early-stage idea to a trial-ready package by funding comprehensive planning, design, and documentation. A major theme is quality control before large amounts of money and participant effort are committed: the R34 allows early peer review of the trial rationale and early assessment of the proposed design and implementation approach, so weaknesses can be identified and corrected before a full clinical trial proposal is submitted.

A key expected outcome of an R34 award under this announcement is a complete, trial-ready clinical trial protocol plus the supporting documents needed to run the study consistently across staff and sites. The FOA highlights development of a Manual of Procedures as a central deliverable, alongside other associated trial documents. These materials are not optional extras; they are required components for any subsequent application to implement the clinical trial through NIDCR’s cooperative agreement mechanism (U01). In other words, the R34 is intended to produce the blueprint, operating playbook, and documentation package that makes a later implementation application feasible and credible.

The FOA also makes clear what NIDCR expects at the end of the planning period. The product of the R34 should be either (1) a submitted application for a clinical trial implementation cooperative agreement (U01), or (2) a written report that summarizes what planning work was completed and explains why the project is not moving forward to a U01 application. This second option acknowledges a practical reality: careful planning sometimes reveals that a proposed trial is not yet justified, not feasible, or not optimally designed, and NIDCR is signaling that reaching a well-supported “no-go” decision can be an acceptable outcome if it is based on solid planning work.

One of the most important administrative requirements in this opportunity is that applicants must obtain pre-approval from NIDCR before submitting an R34 application. That means investigators should expect to communicate with NIDCR program staff ahead of submission to confirm that the proposed planning effort fits NIDCR’s priorities and the intent of the mechanism. This requirement is emphasized as a condition of submission, not merely a suggestion.

In terms of funding structure, this program uses the NIH R34 mechanism, designated here as the NIDCR Clinical Trial Planning grant mechanism. Awards are contingent on the availability of funds and on the submission of meritorious applications, and the announcement does not guarantee a specific number of awards. The activity category is Health, and the CFDA listing associated with the program is 93.121 (Oral Diseases and Disorders Research). There is no cost sharing or matching requirement stated for applicants.

Eligibility is broad and includes many common applicant types across NIH: public and private institutions of higher education, nonprofit organizations (including 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses), and various government entities (state, county, city/township, special districts, independent school districts, public housing authorities, and certain tribal governments and organizations). The eligibility list also extends to several institution types often highlighted in federal funding, such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and faith-based or community-based organizations. Notably, the announcement also indicates that non-U.S. entities (foreign organizations), regional organizations, eligible federal agencies, and U.S. territories or possessions may be eligible, as described in the eligibility clarification text.

Historically, this opportunity was posted July 9, 2008, with an original and current closing date listed as September 7, 2011, and it was archived October 8, 2011. The full announcement was hosted through the NIH Grants Guide under the “PAR 08-195” identifier. Contact assistance for accessing the electronic announcement was routed through the NIH Office of Extramural Research (OER) webmaster email listed in the notice.

Overall, the practical value of this FOA is that it funds the often under-resourced but make-or-break phase of clinical trial development: refining the scientific rationale, locking down the study design, building operational plans, and producing the protocol and procedural documentation needed to credibly request implementation funding later. It is best understood as a bridge between an intervention concept and a fully implementable NIDCR-supported clinical trial submitted as a U01, with an emphasis on early rigor, feasibility, and well-documented execution plans.

Frequently Asked Questions (FAQs): NIDCR Clinical Trial Planning Grant (R34) - PAR 08-195

What is the NIDCR Clinical Trial Planning Grant (R34) opportunity?

It is a discretionary NIH grant program administered by the National Institute of Dental and Craniofacial Research (NIDCR) under Funding Opportunity Number PAR 08-195. The R34 supports the detailed planning work needed before launching an investigator-initiated interventional clinical trial in the dental, oral, and craniofacial space.

What is the main purpose of this R34 funding opportunity?

The central aim is to fund comprehensive clinical trial planning and preparation, not the full conduct of the trial. It supports the upfront effort required to design the study rigorously and develop the core materials expected for a later full-scale clinical trial implementation application.

Does this R34 fund the actual execution of a clinical trial?

No. This mechanism is intended to support planning and development activities before a trial is launched. It is described as funding the blueprint and documentation needed to make a later implementation application feasible and credible.

What types of clinical trials are included in the scope of this FOA?

The FOA focuses on planning for Phase I, II, III, or IV interventional clinical trials in dental, oral, and craniofacial research. It explicitly includes interventional behavioral studies (often described as Stage I through Stage IV behavioral intervention research).

Why does NIDCR use an R34 mechanism for clinical trial planning?

A major theme is quality control before significant resources and participant effort are committed. The R34 provides an opportunity for early peer review of the trial rationale and early assessment of the proposed design and implementation approach, allowing weaknesses to be identified and corrected before a full clinical trial proposal is submitted.

What are the expected deliverables or outcomes of an R34 award under PAR 08-195?

A key expected outcome is a complete, trial-ready clinical trial protocol plus supporting documents needed to run the study consistently across staff and sites. The FOA highlights development of a Manual of Procedures as a central deliverable, along with other associated trial documents.

What is a Manual of Procedures, and why is it emphasized in this FOA?

The FOA identifies the Manual of Procedures as a central deliverable of the planning grant. It is part of the required documentation package needed to support consistent trial operations across personnel and sites and is a required component for any later application to implement the clinical trial through NIDCR's cooperative agreement mechanism (U01).

How does this R34 relate to a future NIDCR clinical trial implementation application?

The R34 is intended to produce the protocol and supporting documents that are required components for a subsequent application to implement the trial through NIDCR's cooperative agreement mechanism (U01). In practical terms, it functions as a bridge from an intervention concept to a trial-ready package suitable for a U01 submission.

What does NIDCR expect at the end of the R34 planning period?

NIDCR expects one of two outcomes: (1) a submitted application for a clinical trial implementation cooperative agreement (U01), or (2) a written report summarizing the planning work completed and explaining why the project is not moving forward to a U01 application.

Is it acceptable if planning reveals the trial should not move forward?

Yes. The FOA acknowledges that careful planning can reveal a proposed trial is not justified, not feasible, or not optimally designed. NIDCR indicates that a well-supported "no-go" outcome can be acceptable when it is based on solid planning work and is documented in a written report.

Is pre-approval from NIDCR required before submitting an R34 application?

Yes. Applicants must obtain pre-approval from NIDCR before submitting an R34 application. Investigators are expected to communicate with NIDCR program staff ahead of submission to confirm the proposed planning effort fits NIDCR priorities and the intent of the mechanism.

Is the pre-approval step optional or just recommended?

It is emphasized as a condition of submission, not merely a suggestion. Applicants should treat it as a required administrative step before applying.

What is the funding mechanism used in this opportunity?

This program uses the NIH R34 mechanism, designated here as the NIDCR Clinical Trial Planning grant mechanism.

Are awards guaranteed under this FOA?

No. Awards are contingent on the availability of funds and the submission of meritorious applications. The announcement does not guarantee a specific number of awards.

Is cost sharing or matching required for applicants?

No cost sharing or matching requirement is stated for applicants in the information provided.

What is the CFDA number associated with this program?

The CFDA listing associated with the program is 93.121 (Oral Diseases and Disorders Research).

What is the activity category listed for this opportunity?

The activity category is Health.

Who is eligible to apply for this R34 opportunity?

Eligibility is broad and includes public and private institutions of higher education, nonprofit organizations (including 501(c)(3) and non-501(c)(3) entities), for-profit organizations (including small businesses), and various government entities such as state, county, city/township, special districts, independent school districts, public housing authorities, and certain tribal governments and organizations.

Are minority-serving institutions and community-based organizations included in the eligibility list?

Yes. The eligibility list includes institution types often highlighted in federal funding, such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and faith-based or community-based organizations.

Are foreign (non-U.S.) organizations eligible to apply?

The announcement indicates that non-U.S. entities (foreign organizations), regional organizations, eligible federal agencies, and U.S. territories or possessions may be eligible, as described in the eligibility clarification text.

When was this funding opportunity originally posted, and what is its status?

The opportunity was posted July 9, 2008. The original and current closing date listed is September 7, 2011, and it was archived October 8, 2011.

Where was the full announcement hosted?

The full announcement was hosted through the NIH Grants Guide under the identifier PAR 08-195.

Who was listed for contact assistance related to accessing the electronic announcement?

Contact assistance for accessing the electronic announcement was routed through the NIH Office of Extramural Research (OER) webmaster email listed in the notice.

In practical terms, what is the value of this FOA for investigators?

It funds the often under-resourced but make-or-break stage of clinical trial development: refining the scientific rationale, locking down the study design, building operational plans, and producing the protocol and procedural documentation needed to credibly request later implementation funding through a U01.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Technological Innovations for Interdisciplinary Research Incorporating the Behavioral and Social Sciences (STTR R41/R42)

Previous opportunity: Geographic and Contextual Influences on Energy Balance Related Health Behaviors (R21)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 08 195

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 08 195) also looked into and applied for these:

Funding Opportunity
NIDCD Clinical Trial Planning Grant (R34) Apply for PAR 08 203

Funding Number: PAR 08 203
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Phase I/II Preliminary Clinical Trials in Communication Disorders (R01) Apply for PAR 08 204

Funding Number: PAR 08 204
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Phase III Definitive Clinical Trials in Communication Disorders (R01) Apply for PAR 08 205

Funding Number: PAR 08 205
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Deep Sequencing and Haplotype Profiling of Mental Disorders (R01) Apply for PA 08 198

Funding Number: PA 08 198
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Addressing the Mental Health Needs of Returning Combat Veterans in the Community (R01) Apply for RFA MH 09 070

Funding Number: RFA MH 09 070
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Deep Sequencing and Haplotype Profiling of Mental Disorders (Collaborative R01) Apply for PAR 08 199

Funding Number: PAR 08 199
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Exploratory/Developmental Projects in Translational Research for Neuromuscular Disease (R21) Apply for PAR 08 228

Funding Number: PAR 08 228
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Translational Research at the Aging/Cancer Interface (TRACI) (R01) Apply for PA 08 230

Funding Number: PA 08 230
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Translational Research at the Aging/Cancer Interface (TRACI) (R21) Apply for PA 08 231

Funding Number: PA 08 231
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
NINDS Exploratory/Developmental Projects in Translational Research (R21) Apply for PAR 08 232

Funding Number: PAR 08 232
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Aging Research Dissertation Awards to Increase Diversity (R36) Apply for PAR 08 250

Funding Number: PAR 08 250
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Archiving and Development of Socialbehavioral Datasets in Aging Related Studies (R03) Apply for PA 08 252

Funding Number: PA 08 252
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Functioning of People with Mental Disorders (R01) Apply for PA 08 255

Funding Number: PA 08 255
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Effects of Alcohol on Glial Cells (R01) Apply for RFA AA 09 003

Funding Number: RFA AA 09 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Effects of Alcohol on Glial Cells (R21) Apply for RFA AA 09 004

Funding Number: RFA AA 09 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Follow up Public Consultation to Inform the Design of a Possible Longitudinal Cohort Study of the Role of Genes and Environment in Health and Disease Limited Competition (U01) Apply for RFA HG 09 004

Funding Number: RFA HG 09 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Institute of Mental Health (NIMH) Career Opportunities in Research (COR) Honors Undergraduate Research Training Grant (T34) Apply for PAR 08 093

Funding Number: PAR 08 093
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Researching Implementation and Change while Improving Quality (R18) Apply for PAR 08 136

Funding Number: PAR 08 136
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
NEI CAREER TRANSITION AWARD (K22) Apply for PAR 04 136

Funding Number: PAR 04 136
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Career Development Award to Promote Diversity in Neuroscience Research Apply for PAR 05 071

Funding Number: PAR 05 071
Agency: National Institutes of Health
Category: Health
Funding Amount: $50,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 08 195", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.